Evidence map›Paper›PMID 37254439›Full record

ArticleNursing open2023

Evaluation of the impact of guideline communication from the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services among US healthcare providers: COVID-19 prevention counselling guidance.

Melanie M Taylor, Arkaprava Deb, Bernita Frazier, James Reiss Lueken, Mansi Das, Joanna Molke, Erin Fitzgerald, Tom Ullian, Ridhu Nair, Marion Couch and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nursing open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Melanie M TaylorCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-1786-6295
Arkaprava DebHospital and Ambulatory Policy Group, Centers for Medicare and Medicaid Services, Woodlawn, Maryland, USA.
Bernita FrazierCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
James Reiss LuekenCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mansi DasOffice of the Assistant Director of Communications, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Joanna MolkeSermo, New York, New York, USA.
Erin FitzgeraldSermo, New York, New York, USA.
Tom UllianRNsights, Braintree, Massachusetts, USA.
Ridhu NairRNsights, Braintree, Massachusetts, USA.
Marion CouchRNsights, Braintree, Massachusetts, USA.
Caitlin TurbyfillCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Libby HorterCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cecilia JoshiCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nickolas DeLucaCOVID-19 Response, State, Tribal, Local, and Territorial Support Task Force, Contact Tracing and Innovation Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate healthcare provider awareness and uptake of the Centers for Medicare & Medicaid Services (CMS) billing for coronavirus disease 2019 (COVID-19) prevention counselling and the delivery of prevention counselling to patients awaiting severe acute respiratory syndrome coronavirus 2 test results.

designCross sectional survey of US-based healthcare providers in February 2021.

methodsAnalysis of associations with healthcare provider-reported awareness of CMS prevention counselling guidance and billing with provider type, specialty, and work setting.

resultsA total of 1919 healthcare providers responded to the survey. Overall, 38% (726/1919) of providers reported awareness of available CMS reimbursement for COVID-19 patient counselling and 29% (465/1614) of CMS billing-eligible providers reported billing for this counselling. Among physicians, those aware of CMS guidance were significantly more likely to bill (58%) versus those unaware (10%). Among RNSights respondents eligible for CMS billing (n = 114), 31% of those aware of the guidance reported billing as compared to 0% of those not aware.

Indexed as

COVID-19MedicareAgedCenters for Disease Control and Prevention, U.S.Centers for Medicare and Medicaid Services, U.S.Cross-Sectional StudiesHealth PersonnelHumansUnited Statescontact tracingCOVID-19MedicaidMedicareprovider billingprovider counsellingreimbursement

Identifiers

PMID37254439
PMCPMC10563432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.